Clarient, Inc. (NASDAQ:CLRT)
CAPS Rating:
The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.
RSS Headlines
Fool UK
Recs
Trending in the right direction - given the investment climate they are managing cash well and able to maintain funding.